1. Home
  2. OGC vs LNTH Comparison

OGC vs LNTH Comparison

Compare OGC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanaGold Corporation Common Shares

OGC

OceanaGold Corporation Common Shares

HOLD

Current Price

$25.65

Market Cap

5.9B

Sector

N/A

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

SELL

Current Price

$100.10

Market Cap

6.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OGC
LNTH
Founded
1990
1956
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.5B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
OGC
LNTH
Price
$25.65
$100.10
Analyst Decision
Hold
Analyst Count
0
10
Target Price
N/A
★ $106.99
AVG Volume (30 Days)
371.6K
★ 965.0K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
★ 1.21%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.91
Revenue
N/A
★ $343,374,000.00
Revenue This Year
$41.93
N/A
Revenue Next Year
$0.30
$12.19
P/E Ratio
★ N/A
$34.35
Revenue Growth
N/A
★ 3.62
52 Week Low
$21.90
$50.16
52 Week High
$31.90
$111.86

Technical Indicators

Market Signals
Indicator
OGC
LNTH
Relative Strength Index (RSI) 36.42 46.56
Support Level $21.90 $99.77
Resistance Level $25.18 $100.40
Average True Range (ATR) 0.92 0.35
MACD -0.16 0.03
Stochastic Oscillator 16.12 34.21

Price Performance

Historical Comparison
OGC
LNTH

About OGC OceanaGold Corporation Common Shares

OceanaGold Corp is a growing intermediate gold and copper producer committed to safely and responsibly maximizing the generation of Free Cash Flow from its operations and delivering robust returns for its shareholders. It has a portfolio of four operating mines: the Haile Gold Mine in the United States of America; the Didipio Mine in the Philippines; and the Macraes and Waihi operations in New Zealand. The company generates key revenue from Haile mines.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: